| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 11.02.2013 (4299
dage). |
Ingen historik.
| Branche | | Ikke-finansielle holdingselskaber (642020). |
| Sidst opdateret den 24.07.2023 og
angivet som gældende fra 19.11.2020 (1461
dage). |
| Historik | Start | Stop |
|---|
| Ikke-finansielle holdingselskaber (642020) | 19.11.2020 | |
| Uoplyst (999999) | 11.02.2013 | 18.11.2020 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 11.03.2015 og
angivet som gældende fra 11.02.2013 (4299
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Navne | | EUROFINS GENOMICS HOLDING DENMARK A/S. |
| Sidst opdateret den 11.02.2013 og
angivet som gældende fra 11.02.2013 (4299
dage). |
Ingen historik.
| Binavne | | Eurofins GenoSkan A/S. |
| Sidst opdateret den 06.09.2023 og
angivet som gældende fra 21.08.2023 (456
dage). |
Ingen historik.
| Tegningsregel | | Selskabet tegnes af den samlede bestyrelse eller af den administrerende direktør i forening med 1 bestyrelsesmedlem. |
| Sidst opdateret den 29.05.2019 og
angivet som gældende fra 29.05.2019 (2001
dage). |
| Fortolkning
(2 tegningsmuligheder)
| | bestyrelsen |
| direktøren + 1 bestyrelsesmedlem |
| Historik | Start | Stop |
|---|
| Selskabet tegnes af den samlede bestyrelse eller af den administrerende direktør i forening med 1 bestyrelsesmedlem | 29.05.2019 | |
| Selskabet tegnes af den samlede bestyrelse eller af bestyrelsesformanden i forening med direktøren eller et bestyrelsesmedlem. | 03.06.2016 | 28.05.2019 |
| Selskabet tegnes af den administrerende direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse | 06.12.2013 | 02.06.2016 |
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:Deloitte Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:33963556
Beskrivelse af revisor:Statsautoriseret revisor
Virksomhedens regnskabsklasse:Reporting class B
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor’s responsibilities for the audit of the financial statements" section of this auditor’s report. We are independent of the Entity in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):We have audited the financial statements of Eurofins Genomics Holding Denmark A/S for the financial year 01. 01. 2022 -31. 12. 2022, which comprise the income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the Entity’s financial position at 31. 12. 2022 and of the results of its operations for the financial year 01. 01. 2022 - 31. 12. 2022 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Management is responsible for the management commentary. Our opinion on the financial statements døs not cover the management commentary, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the management commentary and, in doing so, consider whether the management commentary is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the management commentary provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the management commentary is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the management commentary.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration